The role of adrenal-sparing surgery in the management of aldosterone-producing adenoma: a systematic review and meta-analysis.
Artiles Medina A, Gómez Dos Santos V, Mínguez Ojeda C, Sanjuanbenito A, Gómez-Ramírez J, Mercader E, Hanzu FA, Zarain L, Vidal Ó, Muriel A, Araujo-Castro M.
Eur J Endocrinol. 2025 Aug 29;193(3):S36-S52. doi: 10.1093/ejendo/lvaf180.
Aldosterone-Producing Adenomas.
Hellman P, Björklund P, Åkerström T.
Vitam Horm. 2019;109:407-431. doi: 10.1016/bs.vh.2018.10.007. Epub 2019 Jan 8.
Single-Nucleus Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma.
Murakami M, Hara K, Ikeda K, Horino M, Okazaki R, Niitsu Y, Takeuchi A, Aoki J, Shiba K, Tsujimoto K, Komiya C, Nakamura Y, Kurata M, Akashi T, Fujii Y, Yamada T.
Hypertension. 2024 Feb;81(2):361-371. doi: 10.1161/HYPERTENSIONAHA.123.21446. Epub 2023 Dec 14.
Rare Coexistence of Aldosterone-producing Adrenocortical Adenoma Confirmed by an Immunohistochemical Analysis of Steroidogenic Enzymes with Adrenal Ectopic Thyroid Tissue: A Case Report and Literature Review.
Ohkubo Y, Yamazaki M, Shimada Y, Kubota S, Takayama S, Oiwa A, Yamazaki Y, Sasano H, Komatsu M.
Intern Med. 2024 Jan 15;63(2):259-264. doi: 10.2169/internalmedicine.1630-23. Epub 2023 May 31.
The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.
Lim JS, Rainey WE.
Horm Metab Res. 2020 Jun;52(6):427-434. doi: 10.1055/a-1128-0421. Epub 2020 Mar 30.
Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma.
Nanba K, Blinder AR, Udager AM, Hirokawa Y, Miura T, Okuno H, Moriyoshi K, Yamazaki Y, Sasano H, Yasoda A, Satoh-Asahara N, Rainey WE, Tagami T.
Front Endocrinol (Lausanne). 2024 Mar 5;15:1286297. doi: 10.3389/fendo.2024.1286297. eCollection 2024.
Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings.
Wang H, Wang F, Zhang Y, Wen J, Dong D, Chang X, Sun H, Ma X, Cui Y, Chen S, Lu L, Ren W, Tong A, Li Y.
Front Endocrinol (Lausanne). 2021 Sep 6;12:663096. doi: 10.3389/fendo.2021.663096. eCollection 2021.
Clinical Translationality of KCNJ5 Mutation in Aldosterone Producing Adenoma.
Kitamoto T, Nishikawa T.
Int J Mol Sci. 2022 Aug 12;23(16):9042. doi: 10.3390/ijms23169042.
EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas.
Pang Y, Gong S, Tetti M, Sun Z, Mir-Bashiri S, Bidlingmaier M, Knösel T, Wolf E, Reincke M, Kemter E, Williams TA.
Redox Biol. 2025 Mar;80:103498. doi: 10.1016/j.redox.2025.103498. Epub 2025 Jan 15.
Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review.
Kato H, Kitamoto T, Kimura S, Sunouchi T, Hoshino Y, Hidaka N, Tsurutani Y, Ito N, Makita N, Nishikawa T, Nangaku M, Inoue K.
Endocr Pract. 2024 Jul;30(7):670-678. doi: 10.1016/j.eprac.2024.04.007. Epub 2024 Apr 22.
